SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026346
Filing Date
2022-12-12
Accepted
2022-12-12 09:07:42
Documents
18
Period of Report
2022-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20221206.htm   iXBRL 8-K 72779
2 EX-4.1 sabs-ex4_1.htm EX-4.1 148525
3 EX-4.2 sabs-ex4_2.htm EX-4.2 148755
4 EX-10.1 sabs-ex10_1.htm EX-10.1 464081
5 EX-99.1 sabs-ex99_1.htm EX-99.1 18144
6 GRAPHIC img1871078_0.jpg GRAPHIC 6062
  Complete submission text file 0000950170-22-026346.txt   1120139

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20221206_pre.xml EX-101.PRE 12759
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20221206.xsd EX-101.SCH 3214
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20221206_def.xml EX-101.DEF 13467
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20221206_lab.xml EX-101.LAB 17250
12 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20221206_htm.xml XML 6479
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 221456337
SIC: 2836 Biological Products, (No Diagnostic Substances)